Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
Bascom Palmer Eye Institute
University of Pittsburgh Medical Center
SLT is used to lower intraocular pressure in glaucoma, but it is not know whether the choice of eyedrops administered in the post-operative period affects SLT efficacy. Practitioners commonly use steroid drops, non-steroidal anti-inflammatory drops, or no drops at all. This is a randomized, single-center, prospective, masked clinical trial to determine whether the choice of eyedrop affects efficacy of SLT in glaucoma patients.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
clinical diagnosis of glaucoma
clinician has determined that SLT laser is indicated
IOP currently \>18 and was ever \>21 in the past (e.g. prior to treatment)
You may not be if
prior history of uveitis
prior glaucoma surgery including glaucoma laser surgery